Scientists have developed an experimental vaccine against the Ebola virus that was 100% effective, according to a new study.
The vaccine was not created in time to stop the 2013-2016 Outbreak in Africa, although if they reach more success in the testings this could prevent any future outbreaks.
Many scientists say the the vaccine has compelling results, and could save hundreds of lives.
Among 5,837 people who received the rVSV-EBOV vaccine in the trial in Guinea in 2015, no Ebola cases were recorded 10 days or more after vaccination, signalling 100 percent protection.
In the 2013-2016 Ebola Epidemic virus, over 11,300 people died in West Africa.
Merck’s rVSV-EBOV is now being used in Sierra Leone to help prevent the spread of Ebola.
“When Ebola strikes again we will be in a much better position to offer help to affected communities, as well as protect the brave volunteers who help control this terrible disease,” he said in an emailed statement.
GAVI, the global vaccine alliance, provided $5 million earlier this year to buy 300,000 doses of rVSV-EBOV as a stockpile for use during future Ebola outbreaks.